Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Diagnostic Strategy and Novel Therapeutic Options
Release Date: July 15, 2013
Last Reviewed: July 13, 2013
Expiration Date: July 15, 2014
Time to Complete Activity: 1.25 hours (75 minutes)
*This activity expired for credit on July 15, 2014 and is no longer available for credit
*This activity expired for credit on July 15, 2014 and is no longer available for credit
FACULTY
Anthony Lembo, MD (Chair)
Associate Professor of Medicine
Harvard Medical School
Director, GI Motility
Beth Israel Deaconess Medical Center
Boston, MA
Lucinda A. Harris, MD, MS
Associate Professor of Medicine
Co-Director, Motility
College of Medicine, Mayo Clinic
Consultant, Department of Gastroenterology, Mayo Clinic
Scottsdale, AZ
TARGET AUDIENCE
The educational design of this activity addresses the needs of physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other HCPs involved in the treatment of patients with irritable bowel syndrome and/or chronic idiopathic constipation.
STATEMENT OF NEED
Irritable bowel syndrome (IBS, including subtypes) and chronic idiopathic constipation (CIC) are a significant burden to the healthcare system and, more importantly, to a patient's quality of life. While traditional therapies often fail to address global symptoms of IBS and CIC, novel treatmenet regimens target the pathophysiology of IBS and CIC and fulfill a previously unmet need by providing effective relief of both bowel symptoms and abdominal pain. This interactive on-demand webinar will elucidate the efficacy and safety of these new agents and their role in a comprehensive treatment approach to achieve the goals of symptom relief and improved quality of life.
EDUCATIONAL OBJECTIVES
Upon proper completion of this activity, participants should be better able to:
- Differentiate IBS (and subtypes) and CIC by applying evidence-based diagnostic criteria.
- Identifiy communication techniques that foster shared decision-making among healthcare professionals and patients.
- Incorporate new targeted therapies into treatment plans for patients with IBS (subtypes) or CIC, based on individual patient characteristics and current clinical evidence.
AGENDA
The content of this webinar is viewable on-demand, and participants may navigate through the chapters in any order and at their own pace at their convenience.
| Chapter 1 | Introduction: An Enhanced Understanding of the Heterogeneous Nature of IBS (subtypes) and CIC Anthony Lembo (Chair) | 6 Minutes |
| Chapter 2 | Laying the Foundation for Treatment Success: Evidence-Based Diagnosis and Optimal Patient–Provider Communication Lucinda A. Harris | 27 Minutes |
| Chapter 3 | The IBS (subtypes) and CIC Treatment Arsenal: A Practical Guide to Using New, Targeted Therapies Anthony Lembo | 36 Minutes |
FACULTY AND PLANNER DISCLOSURES
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Anthony Lembo, MD
Retained Consultant: Ardelyx, Inc.; Forest Research Institute, a subsidiary of Forest Laboratories, Inc.; Ironwood Pharmaceuticals; Prometheus, Inc.; Salix Pharmaceuticals, Inc.
Lucinda A. Harris, MD, MS
Retained Consultant: Dyax Corp.; Forest Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Takeda Pharmaceutical Company, Ltd.
Speakers Bureau: Sucampo Pharmaceuticals, Inc.
The planner and managers reported the following financial relationships:
Paradigm Medical Communications, LLC staff members Nancy Salerno, Annette Schwind, MS, CCMEP, and Audrie Tornow, CCMEP have no financial conflicts to disclose.
Global Education Group staff members Amanda Glazar, PhD, Ashley Marosca, RN, MSN and Kristin Delisi, CRNP have no financial conflicts to disclose.
PHYSICIAN CONTINUING EDUCATION
Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACIST CONTINUING EDUCATION
Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Pharmacist Credit Designation Statement
Global Education Group designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – 0530-9999-13-012-H01-P)
This is a knowledge-based activity.
NURSE CONTINUING EDUCATION
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
NURSE PRACTITIONER CONTINUING EDUCATION
Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 1101021.
This program has been approved for 1.25 contact hours of continuing education (which includes 1.25 hours of pharmacology).
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.
DISCLOSURE OF COMMERCIAL SUPPORT
This activity is supported by educational grants from Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, and Salix Pharmaceuticals, Inc.
INSTRUCTIONS FOR PARTICIPATION
In order to receive credit for this activity, the participant must
- Follow instructions to register or log in with your professional information and complete the pretest.
- View the online activity in its entirety.
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the activity.
- A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
There is no fee required for participation in this activity.
HARDWARE/SOFTWARE REQUIREMENTS
This activity is designed as a self-running Flash presentation. In the event that you need this plug-in, a link to download the required Flash Player has been provided below.
Flash Player 10 or later required–download at: http://www.adobe.com/support/flashplayer/downloads.html
For your convenience, you may use the buttons along the top of the screen to navigate between chapters.
SUPPORTED BROWSERS
For Windows: Internet Explorer 7 or higher, Firefox 4.0, Safari 3, Google Chrome, Opera 9.5
For Mac: Safari 3, Firefox 4.0, Google Chrome
Linux: Firefox 4.0
Technical Support:If you have any technical problems or playback issues, please send an email to: contactus@paradigmmc.com.
RESOLUTION OF CONFLICT OF INTEREST
Paradigm Medical Education, LLC (Paradigm) and Global Education Group (Global) require instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Paradigm and Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Paradigm Medical Education, LLC (Paradigm) and Global Education Group (Global) require instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Paradigm and Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
©2012 Paradigm Medical Communications, LLC, except where noted. This web presentation may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Paradigm and Global do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
CONTACT US
For information about the CME-certification of this program (physician credit), please contact Paradigm at (845) 398-5949 or cme@paradigmmc.com.
For information about the CME-certification of this program (physician credit), please contact Paradigm at (845) 398-5949 or cme@paradigmmc.com.
For information about the accreditation of this program (pharmacist, nurse practitioner, or nurse credit), please contact Global at (303) 395-1782 or inquire@globaleducationgroup.com.